Copyright Reports & Markets. All rights reserved.

Global TYK2 Single-target Inhibitor Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of TYK2 Single-target Inhibitor by Type
    • 1.3.1 Overview: Global TYK2 Single-target Inhibitor Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global TYK2 Single-target Inhibitor Consumption Value Market Share by Type in 2025
    • 1.3.3 Oral Preparations
    • 1.3.4 Topical Drugs
  • 1.4 Global TYK2 Single-target Inhibitor Market by Application
    • 1.4.1 Overview: Global TYK2 Single-target Inhibitor Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Psoriasis
    • 1.4.3 Atopic Dermatitis
    • 1.4.4 Other
  • 1.5 Global TYK2 Single-target Inhibitor Market Size & Forecast
  • 1.6 Global TYK2 Single-target Inhibitor Market Size and Forecast by Region
    • 1.6.1 Global TYK2 Single-target Inhibitor Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global TYK2 Single-target Inhibitor Market Size by Region, (2021-2032)
    • 1.6.3 North America TYK2 Single-target Inhibitor Market Size and Prospect (2021-2032)
    • 1.6.4 Europe TYK2 Single-target Inhibitor Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific TYK2 Single-target Inhibitor Market Size and Prospect (2021-2032)
    • 1.6.6 South America TYK2 Single-target Inhibitor Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa TYK2 Single-target Inhibitor Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Bristol-Myers Squibb
    • 2.1.1 Bristol-Myers Squibb Details
    • 2.1.2 Bristol-Myers Squibb Major Business
    • 2.1.3 Bristol-Myers Squibb TYK2 Single-target Inhibitor Product and Solutions
    • 2.1.4 Bristol-Myers Squibb TYK2 Single-target Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.2 InnoCare Pharma
    • 2.2.1 InnoCare Pharma Details
    • 2.2.2 InnoCare Pharma Major Business
    • 2.2.3 InnoCare Pharma TYK2 Single-target Inhibitor Product and Solutions
    • 2.2.4 InnoCare Pharma TYK2 Single-target Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 InnoCare Pharma Recent Developments and Future Plans
  • 2.3 Takeda (Nimbus Therapeutics)
    • 2.3.1 Takeda (Nimbus Therapeutics) Details
    • 2.3.2 Takeda (Nimbus Therapeutics) Major Business
    • 2.3.3 Takeda (Nimbus Therapeutics) TYK2 Single-target Inhibitor Product and Solutions
    • 2.3.4 Takeda (Nimbus Therapeutics) TYK2 Single-target Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Takeda (Nimbus Therapeutics) Recent Developments and Future Plans
  • 2.4 Alumis Inc.
    • 2.4.1 Alumis Inc. Details
    • 2.4.2 Alumis Inc. Major Business
    • 2.4.3 Alumis Inc. TYK2 Single-target Inhibitor Product and Solutions
    • 2.4.4 Alumis Inc. TYK2 Single-target Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Alumis Inc. Recent Developments and Future Plans
  • 2.5 Galapagos NV
    • 2.5.1 Galapagos NV Details
    • 2.5.2 Galapagos NV Major Business
    • 2.5.3 Galapagos NV TYK2 Single-target Inhibitor Product and Solutions
    • 2.5.4 Galapagos NV TYK2 Single-target Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Galapagos NV Recent Developments and Future Plans
  • 2.6 Ventyx Biosciences
    • 2.6.1 Ventyx Biosciences Details
    • 2.6.2 Ventyx Biosciences Major Business
    • 2.6.3 Ventyx Biosciences TYK2 Single-target Inhibitor Product and Solutions
    • 2.6.4 Ventyx Biosciences TYK2 Single-target Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ventyx Biosciences Recent Developments and Future Plans
  • 2.7 BeiGene
    • 2.7.1 BeiGene Details
    • 2.7.2 BeiGene Major Business
    • 2.7.3 BeiGene TYK2 Single-target Inhibitor Product and Solutions
    • 2.7.4 BeiGene TYK2 Single-target Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BeiGene Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global TYK2 Single-target Inhibitor Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of TYK2 Single-target Inhibitor by Company Revenue
    • 3.2.2 Top 3 TYK2 Single-target Inhibitor Players Market Share in 2025
    • 3.2.3 Top 6 TYK2 Single-target Inhibitor Players Market Share in 2025
  • 3.3 TYK2 Single-target Inhibitor Market: Overall Company Footprint Analysis
    • 3.3.1 TYK2 Single-target Inhibitor Market: Region Footprint
    • 3.3.2 TYK2 Single-target Inhibitor Market: Company Product Type Footprint
    • 3.3.3 TYK2 Single-target Inhibitor Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global TYK2 Single-target Inhibitor Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global TYK2 Single-target Inhibitor Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global TYK2 Single-target Inhibitor Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global TYK2 Single-target Inhibitor Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America TYK2 Single-target Inhibitor Consumption Value by Type (2021-2032)
  • 6.2 North America TYK2 Single-target Inhibitor Market Size by Application (2021-2032)
  • 6.3 North America TYK2 Single-target Inhibitor Market Size by Country
    • 6.3.1 North America TYK2 Single-target Inhibitor Consumption Value by Country (2021-2032)
    • 6.3.2 United States TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 6.3.3 Canada TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe TYK2 Single-target Inhibitor Consumption Value by Type (2021-2032)
  • 7.2 Europe TYK2 Single-target Inhibitor Consumption Value by Application (2021-2032)
  • 7.3 Europe TYK2 Single-target Inhibitor Market Size by Country
    • 7.3.1 Europe TYK2 Single-target Inhibitor Consumption Value by Country (2021-2032)
    • 7.3.2 Germany TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 7.3.3 France TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 7.3.5 Russia TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 7.3.6 Italy TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific TYK2 Single-target Inhibitor Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific TYK2 Single-target Inhibitor Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific TYK2 Single-target Inhibitor Market Size by Region
    • 8.3.1 Asia-Pacific TYK2 Single-target Inhibitor Consumption Value by Region (2021-2032)
    • 8.3.2 China TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 8.3.3 Japan TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 8.3.5 India TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 8.3.7 Australia TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America TYK2 Single-target Inhibitor Consumption Value by Type (2021-2032)
  • 9.2 South America TYK2 Single-target Inhibitor Consumption Value by Application (2021-2032)
  • 9.3 South America TYK2 Single-target Inhibitor Market Size by Country
    • 9.3.1 South America TYK2 Single-target Inhibitor Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa TYK2 Single-target Inhibitor Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa TYK2 Single-target Inhibitor Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa TYK2 Single-target Inhibitor Market Size by Country
    • 10.3.1 Middle East & Africa TYK2 Single-target Inhibitor Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)
    • 10.3.4 UAE TYK2 Single-target Inhibitor Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 TYK2 Single-target Inhibitor Market Drivers
  • 11.2 TYK2 Single-target Inhibitor Market Restraints
  • 11.3 TYK2 Single-target Inhibitor Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 TYK2 Single-target Inhibitor Industry Chain
  • 12.2 TYK2 Single-target Inhibitor Upstream Analysis
  • 12.3 TYK2 Single-target Inhibitor Midstream Analysis
  • 12.4 TYK2 Single-target Inhibitor Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global TYK2 Single-target Inhibitor market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global TYK2 Single-target Inhibitor market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global TYK2 Single-target Inhibitor market size and forecasts, in consumption value ($ Million), 2021-2032
    Global TYK2 Single-target Inhibitor market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global TYK2 Single-target Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global TYK2 Single-target Inhibitor market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for TYK2 Single-target Inhibitor
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global TYK2 Single-target Inhibitor market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), Alumis Inc., Galapagos NV, Ventyx Biosciences, BeiGene, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    TYK2 Single-target Inhibitor market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral Preparations
    Topical Drugs
    Market segment by Application
    Psoriasis
    Atopic Dermatitis
    Other
    Market segment by players, this report covers
    Bristol-Myers Squibb
    InnoCare Pharma
    Takeda (Nimbus Therapeutics)
    Alumis Inc.
    Galapagos NV
    Ventyx Biosciences
    BeiGene
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe TYK2 Single-target Inhibitor product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of TYK2 Single-target Inhibitor, with revenue, gross margin, and global market share of TYK2 Single-target Inhibitor from 2021 to 2026.
    Chapter 3, the TYK2 Single-target Inhibitor competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and TYK2 Single-target Inhibitor market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of TYK2 Single-target Inhibitor.
    Chapter 13, to describe TYK2 Single-target Inhibitor research findings and conclusion.

    Buy now